申请人:DAIICHI PHARMACEUTICAL CO., LTD.
公开号:EP1346982A1
公开(公告)日:2003-09-24
The present invention relates to a compound represented by the following formula (I):
(wherein, W represents WA-A1 -WB - (in which, WA is substituted or unsubstituted aryl, etc., A1 is -NR1-, single bond, -C(O)-, etc., and WB is substituted or unsubstituted arylene, etc.), R is single bond, -NH-, -OCH2-, alkenylene, etc., X is -C(O) -CH2-, etc., and M is, for example, the following formula:
(in which, R11, R12 and R13 each independently represents hydrogen, hydroxyl, amino, halogen, etc., R14 is hydrogen or lower alkyl, Y represents -CH2-O-, etc., Z is substituted or unsubstituted arylene, etc., A2 is single bond, etc, and R10 is hydroxyl or lower alkoxy)), or salt thereof; and a medicament containing the same.
This compound or salt thereof selectively inhibits binding of cell adhesion molecules to VAL-4 and exhibits high bioavailability so that it is useful as a preventive and/or remedy for inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, diabetes, and the like.
本发明涉及下式(I)所代表的化合物:
(其中,W代表WA-A1-WB-(其中,WA为取代或未取代的芳基等,A1为-NR1-、单键、-C(O)-等,WB为取代或未取代的芳烯等),R为单键、-NH-、-O -、烯基等,X为-C(O)-
CH2-等,M例如为下式:
(其中,R11、R12 和 R13 各自独立地代表氢、羟基、
氨基、卤素等,R14 是氢或低级烷基,Y 代表- -O-等,Z 是取代或未取代的芳烯等,A2 是单键等,R10 是羟基或低级烷氧基)),或其盐;以及含有相同成分的药物。
该化合物或其盐可选择性地抑制细胞粘附分子与 VAL-4 的结合,并具有高
生物利用度,因此可用于预防和/或治疗炎症性疾病、自身免疫性疾病、转移、支气管哮喘、鼻息肉、糖尿病等。